US$ 24.39
glutathione liver disease Frontiers IV Therapy for Liver Disease
Description
Nowozin, C

Last reviewed: February 2026

This corrected matrix was then analysed using DESeq2 to calculate the adjusted P value in the covariate model

34 , but those results were never published in full or vetted by independent scientists

This suggests that dopaminergic immunomodulation could contribute to the development of this disorder (Fig
